API peptides and proteins-based drugs have gained much attention in the past decade. They are promising therapeutics for the treatment of a variety of metabolic and oncological disorders. More than 100 approved peptide-based therapeutics are currently available in the market.

Victoza, Copaxone, Lupron, Zoladex, Sandostatin, and Somatuline are some of the popularly marketed peptide API therapeutic drugs while more than 600 peptide-based pharmacological leads are being investigated worldwide, across various phases of development.

Peptide API products have become popular due to their proven pharmacological value and favourable safety profiles. The increasing demand for API peptide products is in turn increasing the demand for peptide API manufacturers who also offer contract marketing services.

Discover the top API protein and peptide companies in contract marketing

Pharmaceutical Technology has listed the leading API biologics (protein and peptide) companies in contract marketing based on its intel, insights, and decades-long experience in the sector. The list includes companies that provide various products and services, including:

  • Manufacturing of reagents for peptide synthesis
  • Large-scale manufacturing of peptides
  • Manufacturing of biologically active peptides and complex organic molecules
  • Scale-up of complex peptides
  • Development and production of therapeutic proteins, such as soluble proteins and lipoproteins
  • Process qualification
  • Downstream processing
  • GMP synthesis
  • Synthesis and production of custom peptides
  • Support tech transfer and a wide range of GMP API clinical peptide projects
  • Comprehensive datasets and marketing insights

The information contained within the download document is intended for API peptide and API protein manufacturers, pharmaceutical distributing agencies, pharmaceutical executives, research scientists, medical representatives, pharmacists, business development managers, retail salesmen, sales managers, product marketing managers, retail shop executives, and any other individual involved in API proteins and peptides marketing.

The document contains detailed information on the suppliers and their product offerings, alongside contact details to aid your purchasing or hiring decision.

Technologies in the delivery of peptides and proteins

The advancement in drug design has led to the development of new drug molecules in the form of API peptides and proteins. However, selective delivery of these molecules at well-defined dosing regimens has remained challenging. New techniques are being applied to meet the challenges associated with the formulation and delivery of API peptides and proteins.

Emerging technologies such as 3D printing and bioprinting, electrospinning, electrospraying, microfluidics, nanofluidics, microelectromechanical, and bio-electromechanical systems are being utilised to prepare systems for the delivery of personalised medicine, meeting patient’s needs, and developing old drugs with new processes.